Abstract
Treatment of 1,2-phenylenediamine with benzil analogs in the presence of a mixture of sodium bromate/ sodium hydrogen sulfite in water gave the corresponding quinoxalines in high yields. The method is eco-friendly due to use of water instead of other hazardous organic solvents.
Keywords: Eco-friendly chemistry, high yield, quinoxaline, NaBrO3/NaHSO3 in water.
Graphical Abstract
Letters in Organic Chemistry
Title:Sodium Bromate/Sodium Hydrogen Sulfite: A New Catalyst for the Synthesis of Quinoxaline Derivatives
Volume: 11 Issue: 6
Author(s): Khalid M. Khan, Shafqat Hussain, Shahanaz Perveen, Fazal Rahim, Sammer Yousuf and Ejaz Hussain
Affiliation:
Keywords: Eco-friendly chemistry, high yield, quinoxaline, NaBrO3/NaHSO3 in water.
Abstract: Treatment of 1,2-phenylenediamine with benzil analogs in the presence of a mixture of sodium bromate/ sodium hydrogen sulfite in water gave the corresponding quinoxalines in high yields. The method is eco-friendly due to use of water instead of other hazardous organic solvents.
Export Options
About this article
Cite this article as:
M. Khan Khalid, Hussain Shafqat, Perveen Shahanaz, Rahim Fazal, Yousuf Sammer and Hussain Ejaz, Sodium Bromate/Sodium Hydrogen Sulfite: A New Catalyst for the Synthesis of Quinoxaline Derivatives, Letters in Organic Chemistry 2014; 11 (6) . https://dx.doi.org/10.2174/1570178611666140304000936
DOI https://dx.doi.org/10.2174/1570178611666140304000936 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Designed Multiple Ligands for Cancer Therapy
Current Medicinal Chemistry The Use of Beneficial Microbial Endophytes for Plant Biomass and Stress Tolerance Improvement
Recent Patents on Biotechnology Synthesis of Quinazolines as Tyrosine Kinase Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Coumarins as Potential Anti-drug Resistant Cancer Agents: A Mini Review
Current Topics in Medicinal Chemistry The Fragile X Family of Disorders: A Model for Autism and Targeted Treatments
Current Pediatric Reviews NMDA Receptor Antagonists as Antidepressant and Antidementia Drugs: Recent Developments and Future Prospects
Current Medicinal Chemistry - Central Nervous System Agents The Diterpenoids of the Genus Elaeoselinum (Apiaceae) and their Biological Properties
Current Organic Chemistry Drug Acyl Glucuronides: Reactivity and Analytical Implication
Current Pharmaceutical Analysis Caffeic Acid, A Versatile Pharmacophore: An Overview
Mini-Reviews in Medicinal Chemistry A Patent Review on the Use of L-Asparaginase in the Treatment of Acute Lymphocytic Leukemia
Recent Advances in Drug Delivery and Formulation The Production of Solid Dosage Forms from Non-Degradable Polymers
Current Pharmaceutical Design Chemoprotective Mechanism of the Natural Compounds, Epigallocatechin- 3-O-Gallate, Quercetin and Curcumin Against Cancer and Cardiovascular Diseases
Current Medicinal Chemistry Synthetic Androgens as Designer Supplements
Current Neuropharmacology Antioxidant Treatment and Endothelial Dysfunction: Is it Time for Flavonoids?
Recent Patents on Cardiovascular Drug Discovery Birt-hogg-Dubé Syndrome Incidentally Identified in a Potential Liver Donor
Current Medical Imaging Stimuli Responsive Nanoparticles for Controlled Anti-cancer Drug Release
Current Medicinal Chemistry From Na+/K+-ATPase and Cardiac Glycosides to Cytotoxicity and Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry An Update on Natural Occurrence and Biological Activity of Chromones
Current Medicinal Chemistry Glucokinase Activators for the Potential Treatment of Type 2 Diabetes
Current Topics in Medicinal Chemistry Nitric Oxide Pathway as New Drug Targets for Refractory Hypertension
Current Pharmaceutical Design